We are live on
!
Find out more
ACA
Atlas Capital Advisors Portfolio holdings
AUM
$914M
This Fund
S&P 500
This Quarter
Est. Return
+10.74%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$277M
AUM Growth
+$27.5M
(+11%)
Cap. Flow
-$1.94M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
19.43%
Holding
627
New
66
Increased
111
Reduced
196
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNSR
Finisar Corp
FNSR
|
+$1.49M |
| 2 |
iShares MSCI Canada ETF
EWC
|
+$1.49M |
| 3 |
Duke Energy
DUK
|
+$1.41M |
| 4 |
Biogen
BIIB
|
+$1.36M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMTY
AMERITYRE CORPORATION
AMTY
|
+$2.9M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$1.13M |
| 3 |
CVS Health
CVS
|
+$1.07M |
| 4 |
SHPG
Shire pic
SHPG
|
+$813K |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$724K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.61% |
| 2 | Healthcare | 9.44% |
| 3 | Technology | 8.81% |
| 4 | Financials | 7.96% |
| 5 | Consumer Staples | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Procter & Gamble
PG
$343B
| $12.8M | 4.6% |
122,618
+2,122
| +2% | +$207K |
|
|
2
Vanguard FTSE Pacific ETF
VPL
$8.69B
| $9.14M | 3.3% |
138,840
-11,186
| -7% | -$724K |
|
3
iShares MSCI USA Momentum Factor ETF
MTUM
$24.6B
| $4.58M | 1.65% |
40,870
-628
| -2% | -$67.5K |
|
4
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
| $4.4M | 1.59% |
40,760
-395
| -1% | -$41.5K |
|
5
Vanguard FTSE Europe ETF
VGK
$30.3B
| $4.12M | 1.49% |
76,939
-6,866
| -8% | -$359K |
|
6
Visa
V
$691B
| $3.99M | 1.44% |
25,531
-198
| -0.8% | -$28.5K |
|
7
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $3.84M | 1.39% |
103,820
-9,106
| -8% | -$312K |
|
8
iShares Preferred and Income Securities ETF
PFF
$12.8B
| $3.78M | 1.36% |
103,319
-634
| -0.6% | -$22.8K |
|
9
Amazon
AMZN
$2.71T
| $3.62M | 1.31% |
40,640
| – | – |
|
10
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.29B
| $3.6M | 1.3% |
126,166
+4,215
| +3% | +$116K |
|
11
Regeneron Pharmaceuticals
REGN
$81.3B
| $3.47M | 1.25% |
8,458
| – | – |
|
12
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.4B
| $3.3M | 1.19% |
25,608
+9,728
| +61% | +$1.24M |
|
13
Apple
AAPL
$4.92T
| $2.96M | 1.07% |
62,376
-16,216
| -21% | -$688K |
|
14
Vanguard Morningstar Value ETF
VTV
$190B
| $2.72M | 0.98% |
25,229
-1,353
| -5% | -$142K |
|
15
Vanguard Health Care ETF
VHT
$19.1B
| $2.68M | 0.97% |
15,528
-3,455
| -18% | -$586K |
|
16
Invesco Preferred ETF
PGX
$3.68B
| $2.57M | 0.93% |
177,563
-2,989
| -2% | -$42.5K |
|
17
Intel
INTC
$575B
| $2.35M | 0.85% |
43,779
-7,451
| -15% | -$378K |
|
18
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.19M | 0.79% |
10,926
| – | – |
|
19
Alibaba
BABA
$270B
| $2.19M | 0.79% |
12,000
+3,964
| +49% | +$667K |
|
20
Oracle
ORCL
$455B
| $2.18M | 0.79% |
40,614
-1,298
| -3% | -$66.1K |
|
21
Johnson & Johnson
JNJ
$651B
| $2.17M | 0.78% |
15,533
-1,105
| -7% | -$148K |
|
22
iShares MSCI South Korea ETF
EWY
$27.9B
| $2.13M | 0.77% |
34,868
-1,057
| -3% | -$65.5K |
|
|
AMJ
23
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $2.03M | 0.73% |
79,597
-647
| -0.8% | -$16.2K |
|
|
24
State Street Financial Select Sector SPDR ETF
XLF
$53.4B
| $1.91M | 0.69% |
74,298
-43,590
| -37% | -$1.13M |
|
25
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $1.89M | 0.68% |
20,592
-6,234
| -23% | -$562K |
|
Similar funds
MA
SF
KWMG
ACM
IPAM
PWA
GC
WCM
Atlas Capital Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Atlas Capital Advisors held 627 positions worth $277M, up 11% from $250M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Atlas Capital Advisors's Q1 2019 filing shows 66 new, 111 increased, 196 reduced and 67 closed positions. Its largest new stake was Finisar Corp: 65,342 shares worth $1.51M. The largest sale was AMERITYRE CORPORATION, an estimated $2.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.
- Atlas Capital Advisors's largest Q1 2019 buy was Finisar Corp: 65,342 shares worth $1.51M.
- Atlas Capital Advisors added most to iShares MSCI Canada ETF in Q1 2019, an estimated $1.49M increase.
- Atlas Capital Advisors's biggest Q1 2019 reduction was AMERITYRE CORPORATION, cutting an estimated $2.9M.
- Atlas Capital Advisors fully exited Shire pic in Q1 2019, selling an estimated $813K.
- Atlas Capital Advisors's ten largest holdings make up 19% of its $277M portfolio in Q1 2019.
- Atlas Capital Advisors opened 66 new positions and closed 67 in Q1 2019.
- Atlas Capital Advisors's portfolio value rose 11% quarter-over-quarter to $277M.
Based on Atlas Capital Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.